Immune to Cancer: The CRI Blog
-
CRI Provides Latest Overview of the Field of PDx Trials
PD1 and PDL1 inhibitors, collectively referred to as PDx, have revolutionized cancer treatment since the approval of… -
6 CRI-Affiliated Scientists Elected to the National Academy of Medicine
The National Academy of Medicine (NAM), an organization that has worked on critical issues at the intersection… -
3 Runners on Why They are Fundraising for a Future Immune to Cancer with Team CRI at the TCS New York City Marathon
There are a variety of great ways to fundraise on behalf of the Cancer Research Institute (CRI),… -
New Horizons Opened by Research and Generous Support
A Conversation with Esther M Baird – Passionate Supporter of CRI Research Programs Why is funding scientists… -
This is How CRI Funded Scientists are Fighting Breast Cancer
A Global Challenge Breast cancer poses a formidable challenge to healthcare, being one of the most common… -
Honoring Hispanic Immunologists During National Hispanic Heritage Month
Immunotherapy is the most forward-thinking and promising treatment for many types of cancers. Outcomes for childhood cancers,… -
CRI Remembers Transformational Philanthropist, Chuck Feeney
The Cancer Research Institute mourns the loss of Charles “Chuck” Feeney, an Irish American entrepreneur and philanthropist… -
Prostate Cancer: A Unique and Common Cancer Affecting Men
Most cancers affect everyone, regardless of sex, race, age, and other factors. Prostate cancer, however, only affects… -
2021 William B. Coley Award Recipients Drs. Katalin Karikó and Drew Weissman Receive the 2023 Nobel Prize in Physiology or Medicine
On October 2 the Nobel Assembly at Karolinska Institute in Stockholm, Sweden, announced that the 2023 Nobel…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.